Evaluation of the impact of Covid-19 infection on the evolution and prognosis of patients with acute leukaemia
Authors:
Open Access
- 1 October 2021
- journal article
- research article
- Published by Walter de Gruyter GmbH in Revista Romana de Medicina de Laborator
- Vol. 29 (4) , 377-385
Abstract
Introduciton : COVID19 is one of the largest pandemics. Since December 2019 until now the coronavirus has infected over 131 million people. The mortality rate in the general population varies between 1 to 5%, with a potential of over 30% in patients with neoplasms. Methods : The main objective of the study was to identify some peculiarities of the evolution, complications and treatment of patients with acute leukaemia and COVID-19. The study was retrospective and included 50 patients with acute leukaemia and COVID-19. Results : Recent administration of chemotherapy was identified in 20 patients with acute myeloblastic leukaemia and 4 patients with acute lymphoblastic leukaemia. The newly diagnosed patients or those undergoing intensive chemotherapy, in particular elderly patients, had a severe form of COVID-19 and an unfavourable evolution, and these clinical situations were identified as predictive factors for adverse outcomes. Patients with acute lymphoblastic leukaemia had a shorter survival curve compared to patients with acute myeloblastic leukaemia. Pneumonia was present especially in patients with acute myeloblastic leukaemia, most patients having over 30% of lung fields affected (55.26%). Patients with an unfavourable outcome had significantly increased median values of C-reactive protein, procalcitonin and interleukin6. Conclusions : Patients with acute leukaemia, especially acute myeloblastic leukaemia who have been diagnosed with COVID-19 infection require special attention because they may associate complications and adverse outcomes of COVID-19. The results we obtained require evaluation in a larger group of patients and analysis in the follow-up period after COVID-19.Keywords
This publication has 14 references indexed in Scilit:
- COVID-19 in posttransplant patients—report of 2 casesAmerican Journal of Transplantation, 2022
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort studyThe Lancet Haematology, 2020
- Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front lineInternational Journal of Antimicrobial Agents, 2020
- Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital SystemCancer Discovery, 2020
- Haematological cancers and the risk of severe COVID‐19: Exploration and critical evaluation of the evidence to dateBritish Journal of Haematology, 2020
- Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortalityLeukemia, 2020
- Treating Leukemia in the Time of COVID-19Acta Haematologica, 2020
- Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patientsEBioMedicine, 2020
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19Journal of Clinical Medicine Research, 2020